New York State Common Retirement Fund Concert Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.17 - $4.15 $846 - $1,108	-267 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.77 - $5.24 $87,211 - $121,216	-23,133 Reduced 98.86%	267 $1,000
Q1 2021 May 11, 2021	BUY	$4.86 - $13.07 $19,440 - $52,280	4,000 Added 20.62%	23,400 $117,000
Q1 2020 May 06, 2020	BUY	$5.98 - $13.09 $598 - $1,309	100 Added 0.52%	19,400 $171,000
Q4 2019 Feb 05, 2020	SELL	$5.71 - $9.22 $26,837 - $43,334	-4,700 Reduced 19.58%	19,300 $178,000
Q2 2019 Aug 09, 2019	SELL	$9.44 - $13.12 $13,216 - $18,368	-1,400 Reduced 5.51%	24,000 $288,000
Q3 2018 Nov 07, 2018	SELL	$12.82 - $17.88 $222,991 - $311,004	-17,394 Reduced 40.65%	25,400 $377,000
Q2 2018 Aug 10, 2018	BUY	$16.83 - $21.66 $166,785 - $214,650	9,910 Added 30.14%	42,794 $720,000
Q1 2018 May 10, 2018	BUY	$19.24 - $28.03 $168,407 - $245,346	8,753 Added 36.27%	32,884 $753,000
Q4 2017 Feb 13, 2018	BUY	$13.96 - $29.05 $110,716 - $230,395	7,931 Added 48.96%	24,131 $624,000
Q2 2017 Aug 11, 2017	BUY	N/A	16,200	16,200 $226,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.